Display options
Cite
Stagkourakis S, Kim H, Lyons DJ, et al. Dopamine Autoreceptor Regulation of a Hypothalamic Dopaminergic Network. Cell Rep. 2016;15(4):735-747doi: 10.1016/j.celrep.2016.03.062.
Stagkourakis, S., Kim, H., Lyons, D. J., & Broberger, C. (2016). Dopamine Autoreceptor Regulation of a Hypothalamic Dopaminergic Network. Cell reports, 15(4), 735-747. https://doi.org/10.1016/j.celrep.2016.03.062
Stagkourakis, Stefanos, et al. "Dopamine Autoreceptor Regulation of a Hypothalamic Dopaminergic Network." Cell reports vol. 15,4 (2016): 735-747. doi: https://doi.org/10.1016/j.celrep.2016.03.062
Stagkourakis S, Kim H, Lyons DJ, Broberger C. Dopamine Autoreceptor Regulation of a Hypothalamic Dopaminergic Network. Cell Rep. 2016 Apr 26;15(4):735-747. doi: 10.1016/j.celrep.2016.03.062. Epub 2016 Apr 14. PMID: 27149844; PMCID: PMC4850423.
Copy Download .nbib Format: NLM
Share it on

Cell Rep. 2016 Apr 26;15(4):735-747. doi: 10.1016/j.celrep.2016.03.062. Epub 2016 Apr 14.

Dopamine Autoreceptor Regulation of a Hypothalamic Dopaminergic Network.

Cell reports

Stefanos Stagkourakis, Hoseok Kim, David J Lyons, Christian Broberger

Affiliations

  1. Department of Neuroscience, Karolinska Institutet, 171 77 Stockholm, Sweden. Electronic address: [email protected].
  2. Department of Neuroscience, Karolinska Institutet, 171 77 Stockholm, Sweden.
  3. Department of Neuroscience, Karolinska Institutet, 171 77 Stockholm, Sweden. Electronic address: [email protected].

PMID: 27149844 PMCID: PMC4850423 DOI: 10.1016/j.celrep.2016.03.062

Abstract

How autoreceptors contribute to maintaining a stable output of rhythmically active neuronal circuits is poorly understood. Here, we examine this issue in a dopamine population, spontaneously oscillating hypothalamic rat (TIDA) neurons, that underlie neuroendocrine control of reproduction and neuroleptic side effects. Activation of dopamine receptors of the type 2 family (D2Rs) at the cell-body level slowed TIDA oscillations through two mechanisms. First, they prolonged the depolarizing phase through a combination of presynaptic increases in inhibition and postsynaptic hyperpolarization. Second, they extended the discharge phase through presynaptic attenuation of calcium currents and decreased synaptic inhibition. Dopamine reuptake blockade similarly reconfigured the oscillation, indicating that ambient somatodendritic transmitter concentration determines electrical behavior. In the absence of D2R feedback, however, discharge was abolished by depolarization block. These results indicate the existence of an ultra-short feedback loop whereby neuroendocrine dopamine neurons tune network behavior to echoes of their own activity, reflected in ambient somatodendritic dopamine, and also suggest a mechanism for antipsychotic side effects.

Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Keywords: D2 receptor; arcuate nucleus; auto-inhibition; calcium currents; network oscillation; prolactin; tuberoinfundibular

References

  1. Brain Res. 1983 Jun 13;269(1):177-9 - PubMed
  2. Neuron. 2004 Jun 24;42(6):939-46 - PubMed
  3. Brain Res. 1996 Sep 2;732(1-2):113-20 - PubMed
  4. Brain Res. 1975 Jan 17;83(3):531-7 - PubMed
  5. Arch Neurol. 1974 May;30(5):383-6 - PubMed
  6. J Physiol. 2015 Feb 15;593(4):905-27 - PubMed
  7. Proc Soc Exp Biol Med. 1985 May;179(1):132-5 - PubMed
  8. Neuron. 1997 Jul;19(1):127-38 - PubMed
  9. J Physiol. 1993 Mar;462:753-64 - PubMed
  10. Neurosci Biobehav Rev. 2010 Nov;35(2):151-6 - PubMed
  11. Psychopharmacologia. 1974;39(2):105-19 - PubMed
  12. Neuroendocrinology. 1986;43(3):291-9 - PubMed
  13. J Physiol. 1985 Feb;359:431-46 - PubMed
  14. J Neurosci. 2012 Jun 6;32(23):8074-83 - PubMed
  15. Naunyn Schmiedebergs Arch Pharmacol. 1977 Mar;297(1):1-7 - PubMed
  16. Biol Psychiatry. 1996 Feb 15;39(4):302-4 - PubMed
  17. J Neurophysiol. 2003 Oct;90(4):2402-8 - PubMed
  18. Br J Pharmacol. 1993 Aug;109(4):933-40 - PubMed
  19. Eur J Pharmacol. 1988 May 10;149(3):307-15 - PubMed
  20. J Neurosci. 2010 May 19;30(20):6975-83 - PubMed
  21. Acta Biol Med Ger. 1976;35(6):773-80 - PubMed
  22. Nature. 1998 Oct 29;395(6705):900-5 - PubMed
  23. J Pharm Pharmacol. 1966 Sep;18(9):627-8 - PubMed
  24. Arch Gen Psychiatry. 1978 Jan;35(1):108-16 - PubMed
  25. Neuroendocrinology. 1988 Dec;48(6):663-7 - PubMed
  26. J Neurophysiol. 1995 Dec;74(6):2366-78 - PubMed
  27. Neurosci Lett. 1995 Aug 4;195(2):113-6 - PubMed
  28. Brain Res. 1987 Sep 1;419(1-2):303-10 - PubMed
  29. Endocrinology. 2000 Jan;141(1):366-74 - PubMed
  30. Front Neuroendocrinol. 2014 Oct;35(4):420-38 - PubMed
  31. Pharmacol Biochem Behav. 1973 Jan-Feb;1(1):23-8 - PubMed
  32. Brain Res Bull. 2000 Aug;52(6):567-72 - PubMed
  33. Neuropsychopharmacology. 1997 Aug;17(2):92-9 - PubMed
  34. Brain Res. 1979 Aug 10;171(3):545-51 - PubMed
  35. Endocrinology. 1968 Apr;82(4):878-81 - PubMed
  36. Neuroendocrinology. 1972;9(2):100-22 - PubMed
  37. Biol Psychiatry. 1998 May 15;43(10):713-22 - PubMed
  38. J Pharmacol Exp Ther. 1986 Sep;238(3):1092-100 - PubMed
  39. Trends Neurosci. 1997 Jan;20(1):31-7 - PubMed
  40. Acta Physiol Scand. 1963 Aug;58:383-4 - PubMed
  41. Neuropharmacology. 1991 Sep;30(9):961-5 - PubMed
  42. Endocrinology. 1974 Apr;94(4):1077-85 - PubMed
  43. Endocrinology. 2008 May;149(5):2459-66 - PubMed
  44. Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2866-71 - PubMed
  45. Psychopharmacology (Berl). 1979 Mar 14;61(1):39-41 - PubMed
  46. Life Sci. 2001 Oct 19;69(22):2653-62 - PubMed
  47. Eur Neuropsychopharmacol. 2013 Sep;23(9):999-1009 - PubMed
  48. Neuroendocrinology. 1980 Nov;31(5):316-20 - PubMed
  49. Behav Pharmacol. 1993 Apr;4(2):135-146 - PubMed
  50. Eur J Pharmacol. 1997 Sep 17;335(1):37-42 - PubMed
  51. Neuroscience. 1997 Sep;80(2):545-57 - PubMed
  52. Neuroimage. 2005 Oct 15;28(1):216-26 - PubMed
  53. Physiol Rev. 2000 Oct;80(4):1523-631 - PubMed
  54. Clin Endocrinol (Oxf). 2011 Feb;74(2):141-7 - PubMed
  55. Nature. 1985 Aug 1-7;316(6027):440-3 - PubMed
  56. PLoS Genet. 2014 Sep 25;10(9):e1004574 - PubMed
  57. Neuron. 2010 Jan 28;65(2):217-29 - PubMed
  58. CNS Drug Rev. 2001 Winter;7(4):399-414 - PubMed
  59. J Biomed Sci. 2014 May 03;21:37 - PubMed
  60. Hum Psychopharmacol. 2010 Jun-Jul;25(4):281-97 - PubMed
  61. J Neurosci. 1992 Oct;12(10):3773-80 - PubMed
  62. Psychopharmacologia. 1974;38(2):91-103 - PubMed
  63. J Neurosci. 2015 Mar 11;35(10 ):4229-37 - PubMed
  64. Nature. 1976 Mar 18;260(5548):258-60 - PubMed
  65. Int Clin Psychopharmacol. 2011 May;26(3):130-40 - PubMed
  66. J Neurophysiol. 2013 Nov;110(10):2450-64 - PubMed
  67. J Neural Transm. 1979;46(4):263-77 - PubMed
  68. Neuroendocrinology. 1984 Aug;39(2):189-91 - PubMed
  69. J Neurosci. 2007 Feb 21;27(8):1892-901 - PubMed
  70. J Neurosci. 1997 Aug 1;17(15):5738-46 - PubMed
  71. Endocrinology. 2012 May;153(5):2375-84 - PubMed
  72. J Physiol. 1987 Nov;392:397-416 - PubMed
  73. J Comp Neurol. 1985 Sep 1;239(1):44-53 - PubMed

Publication Types